Detalhe da pesquisa
1.
Molecular MRD status and outcome after transplantation in NPM1-mutated AML.
Blood
; 135(9): 680-688, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932839
2.
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Haematologica
; 109(3): 929-935, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534517
3.
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.
Eur J Haematol
; 107(4): 497-499, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129711
4.
WhiMSICAL: A global Waldenström's Macroglobulinemia patient-derived data registry capturing treatment and quality of life outcomes.
Am J Hematol
; 96(6): E218-E222, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755232
5.
Maori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Clin Lymphoma Myeloma Leuk
; 22(8): e762-e769, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501256
6.
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses.
J Clin Oncol
; 39(8): 890-901, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356418
7.
An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?
J Adolesc Young Adult Oncol
; 8(4): 402-409, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912693
8.
The burden of cancer in 25-29 year olds in New Zealand: a case for a wider adolescent and young adult age range?
N Z Med J
; 131(1468): 15-24, 2018 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346353
9.
Small Numbers, Big Challenges: Adolescent and Young Adult Cancer Incidence and Survival in New Zealand.
J Adolesc Young Adult Oncol
; 6(2): 277-285, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28207291
10.
Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg-->His (Fibrinogen Merivale).
Biochim Biophys Acta
; 1645(2): 146-51, 2003 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12573244
11.
Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia.
Cancer Genet Cytogenet
; 149(2): 125-30, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15036888
12.
Derek Nigel John Hart (1952-2017).
Bone Marrow Transplant
; 54(2): 173-174, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108324
13.
The impact of alcohol-related presentations on a New Zealand hospital emergency department.
N Z Med J
; 127(1401): 23-39, 2014 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25225755
14.
Patterns and sources of alcohol consumption preceding alcohol-affected attendances to a New Zealand hospital emergency department.
N Z Med J
; 127(1401): 40-55, 2014 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25225756
15.
Burnout in hospital-based medical consultants in the New Zealand public health system.
N Z Med J
; 122(1300): 11-8, 2009 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19701256
16.
Written advice can provide a safe and acceptable alternative to new patient assessment for selected referrals to haematologists.
Med J Aust
; 188(1): 9-12, 2008 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18205554
17.
The outcome of clinical parameters in adults with severe Type I Gaucher disease using very low dose enzyme replacement therapy.
Mol Genet Metab
; 92(1-2): 131-6, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17604204
18.
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
Biol Blood Marrow Transplant
; 12(2): 217-25, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16443519
19.
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.
Blood
; 108(1): 88-96, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16556892
20.
EOG as a monitor of desferrioxamine retinal toxicity.
Doc Ophthalmol
; 109(3): 273-8, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15957612